Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C024566 |
1,1,1-trichloroethane |
1,1,1-trichloroethane results in decreased activity of [GRIN1 protein binds to GRIN2A protein] | affects binding|decreases activity | 11090101
|
C024566 |
1,1,1-trichloroethane |
1,1,1-trichloroethane results in decreased activity of [GRIN1 protein binds to GRIN2B protein] | affects binding|decreases activity | 11090101
|
C025603 |
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid |
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid affects the activity of GRIN1 protein | affects activity | 16139540
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of GRIN1 mRNA | affects expression | 21346803
|
C076996 |
27-hydroxycholesterol |
27-hydroxycholesterol results in decreased expression of GRIN1 protein | decreases expression | 18503570
|
C079215 |
3,5-dihydroxyphenylglycine |
3,5-dihydroxyphenylglycine results in increased phosphorylation of GRIN1 protein | increases phosphorylation | 16600209
|
C079215 |
3,5-dihydroxyphenylglycine |
6-methyl-2-(phenylethynyl)pyridine inhibits the reaction [N-(4-chloro-2-((1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl)phenyl)-2-hydroxybenzamide promotes the reaction [3,5-dihydroxyphenylglycine results in increased phosphorylation of GRIN1 protein]] | decreases reaction|increases phosphorylation|increases reaction | 16600209
|
C079215 |
3,5-dihydroxyphenylglycine |
N-(4-chloro-2-((1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl)phenyl)-2-hydroxybenzamide promotes the reaction [3,5-dihydroxyphenylglycine results in increased phosphorylation of GRIN1 protein] | increases phosphorylation|increases reaction | 16600209
|
C121465 |
6-methyl-2-(phenylethynyl)pyridine |
6-methyl-2-(phenylethynyl)pyridine inhibits the reaction [N-(4-chloro-2-((1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl)phenyl)-2-hydroxybenzamide promotes the reaction [3,5-dihydroxyphenylglycine results in increased phosphorylation of GRIN1 protein]] | decreases reaction|increases phosphorylation|increases reaction | 16600209
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of GRIN1 mRNA | affects expression | 16483693
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the localization of GRIN1 protein | affects localization | 16678351
|
D000643 |
Ammonium Chloride |
Ammonium Chloride results in increased phosphorylation of GRIN1 protein | increases phosphorylation | 16678351
|
D000661 |
Amphetamine |
Amphetamine results in increased phosphorylation of GRIN1 protein | increases phosphorylation | 14622123
|
D001554 |
Benzene |
Benzene results in decreased activity of [GRIN1 protein binds to GRIN2A protein] | affects binding|decreases activity | 11090101
|
D001554 |
Benzene |
Benzene results in decreased activity of [GRIN1 protein binds to GRIN2B protein] | affects binding|decreases activity | 11090101
|
C070515 |
bisindolylmaleimide I |
bisindolylmaleimide I inhibits the reaction [CARTPT protein results in increased phosphorylation of GRIN1 protein] | decreases reaction|increases phosphorylation | 19632277
|
C006780 |
bisphenol A |
bisphenol A results in increased expression of GRIN1 protein | increases expression | 12411739
|
C031938 |
calmidazolium |
calmidazolium affects the activity of GRIN1 protein | affects activity | 16139540
|
C059041 |
calyculin A |
calyculin A results in increased activity of GRIN1 protein | increases activity | 16139540
|
D004390 |
Chlorpyrifos |
Chlorpyrifos results in increased expression of GRIN1 mRNA | increases expression | 19440498
|
D003024 |
Clozapine |
Clozapine results in decreased expression of GRIN1 mRNA | decreases expression | 17266109
|
D003024 |
Clozapine |
Clozapine results in decreased expression of GRIN1 mRNA | decreases expression | 12608697
|
D003024 |
Clozapine |
Clozapine results in increased expression of GRIN1 mRNA | increases expression | 12020038 18923069
|
C017160 |
cypermethrin |
cypermethrin affects the activity of GRIN1 protein | affects activity | 16139540
|
D004026 |
Dieldrin |
Dieldrin results in increased expression of GRIN1 mRNA | increases expression | 19440498
|
D004041 |
Dietary Fats |
Dietary Fats results in decreased expression of GRIN1 protein | decreases expression | 18503570
|
D004051 |
Diethylhexyl Phthalate |
Diethylhexyl Phthalate results in decreased expression of GRIN1 mRNA | decreases expression | 15518916
|
D016291 |
Dizocilpine Maleate |
Dizocilpine Maleate promotes the reaction [GRIN1 protein binds to SRC protein] | affects binding|increases reaction | 11249956
|
D004298 |
Dopamine |
[Dopamine results in increased activity of DRD1A protein] which results in increased phosphorylation of GRIN1 protein | increases activity|increases phosphorylation | 14622123
|
D004298 |
Dopamine |
N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [[Dopamine results in increased activity of DRD1A protein] which results in increased phosphorylation of GRIN1 protein] | decreases reaction|increases activity|increases phosphorylation | 14622123
|
D004958 |
Estradiol |
[Lithium Chloride co-treated with Estradiol] results in decreased expression of GRIN1 mRNA | affects cotreatment|decreases expression | 19285052
|
D004958 |
Estradiol |
[[Lithium Chloride co-treated with Estradiol] results in decreased expression of GRIN1 mRNA] which affects the susceptibility to Excitatory Amino Acid Agonists | affects cotreatment|affects response to substance|decreases expression | 19285052
|
D004958 |
Estradiol |
Estradiol results in increased expression of GRIN1 protein | increases expression | 12411739
|
D000431 |
Ethanol |
Ethanol results in decreased expression of GRIN1 mRNA | decreases expression | 18713641
|
D000431 |
Ethanol |
Ethanol results in increased expression of GRIN1 protein | increases expression | 12045474
|
C004912 |
ethylbenzene |
ethylbenzene results in decreased activity of [GRIN1 protein binds to GRIN2A protein] | affects binding|decreases activity | 11090101
|
C004912 |
ethylbenzene |
ethylbenzene results in decreased activity of [GRIN1 protein binds to GRIN2B protein] | affects binding|decreases activity | 11090101
|
D018690 |
Excitatory Amino Acid Agonists |
Excitatory Amino Acid Agonists binds to and results in increased activity of [GRIN1 protein binds to GRIN2A protein] | affects binding|increases activity | 11812690
|
D018690 |
Excitatory Amino Acid Agonists |
Urethane inhibits the reaction [Excitatory Amino Acid Agonists binds to and results in increased activity of [GRIN1 protein binds to GRIN2A protein]] | affects binding|decreases reaction|increases activity | 11812690
|
D018690 |
Excitatory Amino Acid Agonists |
[[Lithium Chloride co-treated with Estradiol] results in decreased expression of GRIN1 mRNA] which affects the susceptibility to Excitatory Amino Acid Agonists | affects cotreatment|affects response to substance|decreases expression | 19285052
|
D018690 |
Excitatory Amino Acid Agonists |
Excitatory Amino Acid Agonists results in decreased expression of GRIN1 protein | decreases expression | 17550430
|
D005576 |
Forskolin |
Forskolin results in increased phosphorylation of GRIN1 protein | increases phosphorylation | 14622123
|
D005576 |
Forskolin |
N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Forskolin results in increased phosphorylation of GRIN1 protein] | decreases reaction|increases phosphorylation | 14622123
|
D005839 |
Gentamicins |
Gentamicins results in increased expression of GRIN1 mRNA | increases expression | 15200423
|
D005839 |
Gentamicins |
Gentamicins results in increased expression of GRIN1 protein | increases expression | 15200423
|
D006220 |
Haloperidol |
Haloperidol results in decreased expression of GRIN1 mRNA | decreases expression | 12020038
|
D006220 |
Haloperidol |
Haloperidol results in increased expression of GRIN1 mRNA | increases expression | 12020038
|
D016627 |
Oxidopamine |
Oxidopamine results in decreased expression of GRIN1 mRNA | decreases expression | 15518916
|
C057416 |
KT 5720 |
KT 5720 inhibits the reaction [CARTPT protein results in increased phosphorylation of GRIN1 protein] | decreases reaction|increases phosphorylation | 19632277
|
D018021 |
Lithium Chloride |
[Lithium Chloride co-treated with Estradiol] results in decreased expression of GRIN1 mRNA | affects cotreatment|decreases expression | 19285052
|
D018021 |
Lithium Chloride |
[[Lithium Chloride co-treated with Estradiol] results in decreased expression of GRIN1 mRNA] which affects the susceptibility to Excitatory Amino Acid Agonists | affects cotreatment|affects response to substance|decreases expression | 19285052
|
D018021 |
Lithium Chloride |
Lithium Chloride results in decreased expression of GRIN1 mRNA | decreases expression | 19285052
|
C063509 |
N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide |
N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [[2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine results in increased activity of DRD1A protein] which results in increased phosphorylation of GRIN1 protein] | decreases reaction|increases activity|increases phosphorylation | 14622123
|
C063509 |
N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide |
N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [[Dopamine results in increased activity of DRD1A protein] which results in increased phosphorylation of GRIN1 protein] | decreases reaction|increases activity|increases phosphorylation | 14622123
|
C063509 |
N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide |
N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Forskolin results in increased phosphorylation of GRIN1 protein] | decreases reaction|increases phosphorylation | 14622123
|
C481448 |
N-(4-chloro-2-((1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl)phenyl)-2-hydroxybenzamide |
6-methyl-2-(phenylethynyl)pyridine inhibits the reaction [N-(4-chloro-2-((1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl)phenyl)-2-hydroxybenzamide promotes the reaction [3,5-dihydroxyphenylglycine results in increased phosphorylation of GRIN1 protein]] | decreases reaction|increases phosphorylation|increases reaction | 16600209
|
C481448 |
N-(4-chloro-2-((1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl)phenyl)-2-hydroxybenzamide |
N-(4-chloro-2-((1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl)phenyl)-2-hydroxybenzamide promotes the reaction [3,5-dihydroxyphenylglycine results in increased phosphorylation of GRIN1 protein] | increases phosphorylation|increases reaction | 16600209
|
D015058 |
1-Naphthylisothiocyanate |
1-Naphthylisothiocyanate results in decreased expression of GRIN1 mRNA | decreases expression | 12832660
|
C025256 |
nonylphenol |
nonylphenol results in decreased expression of GRIN1 mRNA | decreases expression | 15518916
|
C024268 |
n-propylbenzene |
n-propylbenzene results in decreased activity of [GRIN1 protein binds to GRIN2A protein] | affects binding|decreases activity | 11090101
|
C024268 |
n-propylbenzene |
n-propylbenzene results in decreased activity of [GRIN1 protein binds to GRIN2B protein] | affects binding|decreases activity | 11090101
|
D019319 |
Okadaic Acid |
Okadaic Acid results in increased activity of GRIN1 protein | increases activity | 16139540
|
D010269 |
Paraquat |
Paraquat results in decreased expression of GRIN1 mRNA | decreases expression | 19146868
|
D010278 |
Parathion |
Parathion results in decreased expression of GRIN1 mRNA | decreases expression | 19146868
|
D010424 |
Pentobarbital |
Pentobarbital affects the expression of GRIN1 mRNA | affects expression | 10717408
|
D010622 |
Phencyclidine |
Phencyclidine results in decreased expression of GRIN1 mRNA | decreases expression | 17266109
|
D010795 |
Phthalic Acids |
Phthalic Acids results in decreased expression of GRIN1 mRNA | decreases expression | 15518916
|
D013467 |
Sulindac |
Sulindac affects the expression of GRIN1 protein | affects expression | 15123337
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of GRIN1 mRNA | decreases expression | 14984010
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of GRIN1 protein | decreases expression | 14984010
|
D015647 |
2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine |
[2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine results in increased activity of DRD1A protein] which results in increased phosphorylation of GRIN1 protein | increases activity|increases phosphorylation | 14622123
|
D015647 |
2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine |
N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [[2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine results in increased activity of DRD1A protein] which results in increased phosphorylation of GRIN1 protein] | decreases reaction|increases activity|increases phosphorylation | 14622123
|
D013849 |
Thimerosal |
Thimerosal results in decreased expression of GRIN1 protein | decreases expression | 15184908
|
D024505 |
Tocopherols |
Tocopherols results in increased expression of GRIN1 mRNA | increases expression | 17654050
|
D014050 |
Toluene |
Toluene results in decreased activity of [GRIN1 protein binds to GRIN2A protein] | affects binding|decreases activity | 9655877
|
D014050 |
Toluene |
Toluene results in decreased activity of [GRIN1 protein binds to GRIN2B protein] | affects binding|decreases activity | 9655877
|
D014520 |
Urethane |
Urethane inhibits the reaction [Excitatory Amino Acid Agonists binds to and results in increased activity of [GRIN1 protein binds to GRIN2A protein]] | affects binding|decreases reaction|increases activity | 11812690
|
D014992 |
Xylenes |
Xylenes results in decreased activity of [GRIN1 protein binds to GRIN2A protein] | affects binding|decreases activity | 11090101
|
D014992 |
Xylenes |
Xylenes results in decreased activity of [GRIN1 protein binds to GRIN2B protein] | affects binding|decreases activity | 11090101
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Sulindac |
4.96 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Diethylhexyl Phthalate |
11.37 | 6734493 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Ethanol |
11.37 | 18926900 17676605 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
11.37 | 11752688 15322242 14514962 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
8.72 | 18287403 |
MESH:D000138 |
Acidosis |
|
Ethanol |
8.72 | 11192467 |
MESH:D058186 |
Acute Kidney Injury |
|
Gentamicins |
7.71 | 11274264 |
MESH:D058186 |
Acute Kidney Injury |
|
Sulindac |
7.71 | 7897758 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
6.40 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Sulindac |
6.40 | 11910360 |
MESH:D000230 |
Adenocarcinoma |
|
Urethane |
6.40 | 18316556 |
MESH:D002282 |
Adenocarcinoma, Bronchiolo-Alveolar |
|
Urethane |
5.17 | 15814487 |
MESH:D000236 |
Adenoma |
|
Sulindac |
6.38 | 10223192 |
MESH:D000236 |
Adenoma |
|
Urethane |
6.38 | 10822126 10530776 16926031 17093202 6695378 17195641 11497255 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
2.85 | 16835633 |
MESH:D011125 |
Adenomatous Polyposis Coli |
|
Sulindac |
4.14 | 11874996 11535846 16460482 19003578 15623613 12394442 17611924 |
MESH:D000380 |
Agranulocytosis |
|
Clozapine |
4.54 | 14617031 16160616 12649775 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Chlorpyrifos |
16.25 | 11874814 16611668 17119214 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
cypermethrin |
16.25 | 16487989 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Paraquat |
16.25 | 11874814 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Parathion |
16.25 | 17119214 11874814 |
MESH:D020268 |
Alcohol-Induced Disorders, Nervous System |
|
Ethanol |
4.78 | 15451039 15451040 |
MESH:D000544 |
Alzheimer Disease |
|
27-hydroxycholesterol |
3.60 | 14523054 20157255 |
MESH:D019969 |
Amphetamine-Related Disorders |
|
Amphetamine |
5.53 | 15010207 16916582 18475255 16459022 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.49 | 11748828 |
MESH:D000741 |
Anemia, Aplastic |
|
Benzene |
3.96 | 14761424 11369114 17661222 |
MESH:D000853 |
Anophthalmos |
|
Ethanol |
4.30 | 15513904 |
MESH:D000855 |
Anorexia |
|
2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine |
9.35 | 12183048 |
MESH:D000855 |
Anorexia |
|
Amphetamine |
9.35 | 12183048 16084549 16101753 12005258 |
MESH:D001008 |
Anxiety Disorders |
|
Ethanol |
8.01 | 11141031 |
MESH:D001008 |
Anxiety Disorders |
|
Pentobarbital |
8.01 | 11141031 18313124 |
MESH:D001145 |
Arrhythmias, Cardiac |
|
Xylenes |
5.08 | 513065 |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
3.38 | 15238619 |
MESH:D050197 |
Atherosclerosis |
|
27-hydroxycholesterol |
4.11 | 11166758 9059518 |
MESH:D001289 |
Attention Deficit Disorder with Hyperactivity |
|
Oxidopamine |
7.70 | 14699433 |
MESH:D001289 |
Attention Deficit Disorder with Hyperactivity |
|
Phthalic Acids |
7.70 | 20106747 |
MESH:D001321 |
Autistic Disorder |
|
Haloperidol |
2.81 | 18080171 19368416 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
2.57 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.25 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.41 | 15746008 |
MESH:D001855 |
Bone Marrow Diseases |
|
Benzene |
4.69 | 16183116 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
3.39 | 11985600 |
MESH:D001913 |
Bowen's Disease |
|
Sulindac |
4.82 | 11207687 |
MESH:D001943 |
Breast Neoplasms |
|
Benzene |
4.17 | 11921183 17162533 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
4.17 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
Dieldrin |
4.17 | 11859874 15770527 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
4.17 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
4.17 | 14630087 17289903 17018787 12948864 18497071 16675129 17261762 19861407 |
MESH:D001943 |
Breast Neoplasms |
|
Parathion |
4.17 | 12762645 |
MESH:D001943 |
Breast Neoplasms |
|
Sulindac |
4.17 | 16642371 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
4.17 | 20435547 |
MESH:D002056 |
Burns |
|
Ethanol |
4.14 | 16374292 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
3.93 | 16111702 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.38 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
4.04 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
4.04 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Ethanol |
4.04 | 15763234 15289165 18788625 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
4.46 | 17123778 |
MESH:D006332 |
Cardiomegaly |
|
Ethanol |
5.80 | 19332462 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
5.80 | 16120746 18670907 18850075 |
MESH:D002375 |
Catalepsy |
|
Haloperidol |
4.38 | 1977408 15215559 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
5.43 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
5.43 | 18566989 |
MESH:D002547 |
Cerebral Palsy |
|
Toluene |
5.32 | 9294310 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
2.72 | 16835633 |
MESH:D002761 |
Cholangitis |
|
1-Naphthylisothiocyanate |
5.66 | 12912871 |
MESH:D002779 |
Cholestasis |
|
1-Naphthylisothiocyanate |
3.93 | 15500046 18590720 18164287 12927374 19486331 7624871 15913567 16629650 |
MESH:D002780 |
Cholestasis, Intrahepatic |
|
1-Naphthylisothiocyanate |
5.32 | 10220858 19407337 |
MESH:D002971 |
Cleft Lip |
|
Ethanol |
3.29 | 15513904 |
MESH:D002972 |
Cleft Palate |
|
Ethanol |
8.54 | 15513904 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
8.54 | 15668235 8697196 12621046 15340226 16354765 |
MESH:D002972 |
Cleft Palate |
|
Urethane |
8.54 | 12810352 |
MESH:D003072 |
Cognition Disorders |
|
Clozapine |
4.45 | 17123785 |
MESH:D003110 |
Colonic Neoplasms |
|
Sulindac |
2.82 | 12902858 12458338 |
MESH:D015179 |
Colorectal Neoplasms |
|
Sulindac |
2.68 | 11076880 10666051 18059344 11197048 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.61 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
6-methyl-2-(phenylethynyl)pyridine |
6.56 | 17065172 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Benzene |
6.56 | 15643154 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Ethanol |
6.56 | 11198716 19302082 15451040 11873399 15513904 15451039 10194807 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
6.56 | 15322242 10048152 20055451 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Toluene |
6.56 | 9294310 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
3.50 | 18551238 |
MESH:D003643 |
Death |
|
Toluene |
5.13 | 6431079 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
Haloperidol |
4.36 | 20210726 |
MESH:D003704 |
Dementia |
|
Haloperidol |
4.11 | 11575062 |
MESH:D003715 |
Dengue |
|
27-hydroxycholesterol |
5.15 | 19427377 |
MESH:D003872 |
Dermatitis |
|
Benzene |
4.25 | 15902427 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Thimerosal |
4.05 | 15932584 16958921 |
MESH:D003876 |
Dermatitis, Atopic |
|
Diethylhexyl Phthalate |
3.78 | 16882537 |
MESH:D017453 |
Dermatitis, Irritant |
|
Xylenes |
6.30 | 17574719 |
MESH:D002658 |
Developmental Disabilities |
|
Thimerosal |
4.48 | 15764492 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Clozapine |
3.98 | 16402076 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
3.98 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
2.97 | 19279558 |
MESH:D003930 |
Diabetic Retinopathy |
|
Sulindac |
4.68 | 12861449 17621415 |
MESH:D006970 |
Disorders of Excessive Somnolence |
|
Clozapine |
5.02 | 15331141 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
1,1,1-trichloroethane |
10.07 | 6623471 2862719 4356632 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
1-Naphthylisothiocyanate |
10.07 | 17522070 7624871 18289764 20133375 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
10.07 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Ethanol |
10.07 | 11566570 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
10.07 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Gentamicins |
7.07 | 15033597 11033412 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
7.07 | 11462148 |
MESH:D050171 |
Dyslipidemias |
|
Clozapine |
7.57 | 16402076 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
7.57 | 18367378 |
MESH:D004417 |
Dyspnea |
|
cypermethrin |
4.85 | 16487989 |
MESH:D004487 |
Edema |
|
bisindolylmaleimide I |
5.72 | 8273558 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
5.72 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.36 | 16714409 15322242 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
27-hydroxycholesterol |
4.68 | 17410599 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
2.63 | 18566989 11473722 19148513 |
MESH:D004715 |
Endometriosis |
|
Sulindac |
7.67 | 15652904 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
7.67 | 10568697 9294722 |
MESH:D004938 |
Esophageal Neoplasms |
|
Ethanol |
4.47 | 16704527 |
MESH:D004938 |
Esophageal Neoplasms |
|
Sulindac |
4.47 | 12235107 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.61 | 11564622 |
MESH:D005221 |
Fatigue |
|
Amphetamine |
5.07 | 19890266 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
6.50 | 18296743 17967931 19004024 19551842 |
MESH:D005234 |
Fatty Liver |
|
Ethanol |
6.50 | 19236843 18620774 16409862 |
MESH:D005235 |
Fatty Liver, Alcoholic |
|
Ethanol |
5.13 | 17920746 |
MESH:D005310 |
Fetal Alcohol Syndrome |
|
Ethanol |
4.77 | 16946407 15451040 10194807 15513904 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
2.94 | 11858732 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Sulindac |
4.95 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Sulindac |
4.60 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
6.92 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
6.92 | 20067830 |
MESH:D005756 |
Gastritis |
|
Ethanol |
4.16 | 15046732 |
MESH:D005764 |
Gastroesophageal Reflux |
|
Sulindac |
4.51 | 11910360 |
MESH:D005909 |
Glioblastoma |
|
Okadaic Acid |
4.28 | 17312396 |
MESH:D005911 |
Gliosis |
|
Paraquat |
4.62 | 11124998 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.05 | 10696789 |
MESH:D034381 |
Hearing Loss |
|
Gentamicins |
4.44 | 19130971 17868369 18024279 15968427 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.04 | 10048152 11294989 |
MESH:D006331 |
Heart Diseases |
|
Urethane |
3.87 | 16046796 |
MESH:D006402 |
Hematologic Diseases |
|
Benzene |
4.17 | 16183116 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
2.86 | 11000095 |
MESH:D006505 |
Hepatitis |
|
1-Naphthylisothiocyanate |
8.58 | 18590720 |
MESH:D006505 |
Hepatitis |
|
cypermethrin |
8.58 | 16487989 |
MESH:D006521 |
Hepatitis, Chronic |
|
1,1,1-trichloroethane |
6.29 | 12594376 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.39 | 16120746 15340226 12621046 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.49 | 15709030 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.22 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Lithium Chloride |
11.24 | 19797860 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
11.24 | 16354765 8697196 18606429 15340226 16959395 |
MESH:D006930 |
Hyperalgesia |
|
Ethanol |
3.30 | 18783367 |
MESH:D053565 |
Hypercalciuria |
|
Gentamicins |
5.18 | 17652376 |
MESH:D006937 |
Hypercholesterolemia |
|
27-hydroxycholesterol |
8.07 | 17873880 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
8.07 | 21332399 |
MESH:D006948 |
Hyperkinesis |
|
Amphetamine |
10.05 | 1977408 14960337 |
MESH:D006948 |
Hyperkinesis |
|
Clozapine |
10.05 | 16046005 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
3.13 | 21332399 |
MESH:D006973 |
Hypertension |
|
Benzene |
4.55 | 17940673 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
4.55 | 18670907 18850075 |
MESH:D007022 |
Hypotension |
|
Dopamine |
4.53 | 6740701 |
MESH:D007247 |
Infertility, Female |
|
Dieldrin |
4.45 | 10630421 |
MESH:D007248 |
Infertility, Male |
|
Paraquat |
6.27 | 4850670 |
MESH:D007248 |
Infertility, Male |
|
Parathion |
6.27 | 16029889 |
MESH:D007249 |
Inflammation |
|
bisindolylmaleimide I |
9.61 | 8273558 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
9.61 | 20412841 |
MESH:D007249 |
Inflammation |
|
Sulindac |
9.61 | 3291741 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
9.61 | 12878042 12200463 |
MESH:D007299 |
Insect Bites and Stings |
|
cypermethrin |
5.44 | 15189238 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
10.30 | 16393666 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
10.30 | 11836018 18457598 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
10.30 | 16393666 16627594 |
MESH:D007414 |
Intestinal Neoplasms |
|
Sulindac |
4.18 | 10213222 12584176 12663524 12351151 12628509 10223192 |
MESH:D007417 |
Intestinal Polyps |
|
Sulindac |
4.50 | 11245490 12394442 |
MESH:D007569 |
Jaw Abnormalities |
|
Ethanol |
8.54 | 15513904 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
8.54 | 16580747 |
MESH:D007673 |
Kidney Cortex Necrosis |
|
Gentamicins |
5.19 | 18842672 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
5.42 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
Gentamicins |
5.42 | 17934191 18289764 19349640 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
5.94 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
5.94 | 15610895 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Gentamicins |
4.84 | 11231351 |
MESH:D007859 |
Learning Disorders |
|
Ethanol |
3.70 | 15451040 |
MESH:D016773 |
Leishmaniasis, Cutaneous |
|
Gentamicins |
4.03 | 10219319 |
MESH:D007938 |
Leukemia |
|
Benzene |
3.11 | 17119257 14694614 15935818 18335105 |
MESH:D007951 |
Leukemia, Myeloid |
|
Benzene |
3.85 | 17506065 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Benzene |
2.60 | 19478238 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Ethanol |
3.43 | 17676605 |
MESH:D008064 |
Lipidoses |
|
Clozapine |
3.58 | 17567588 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
5.80 | 18296743 |
MESH:D008103 |
Liver Cirrhosis |
|
Ethanol |
5.80 | 15289165 |
MESH:D008104 |
Liver Cirrhosis, Alcoholic |
|
Ethanol |
4.57 | 18295389 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
Sulindac |
3.88 | 12468960 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
3.07 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Ethanol |
3.07 | 18166357 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.07 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
1-Naphthylisothiocyanate |
8.21 | 17184895 |
MESH:D008107 |
Liver Diseases |
|
Chlorpyrifos |
8.21 | 15991261 |
MESH:D008107 |
Liver Diseases |
|
cypermethrin |
8.21 | 15991261 |
MESH:D008107 |
Liver Diseases |
|
Sulindac |
8.21 | 14986274 16867024 |
MESH:D008108 |
Liver Diseases, Alcoholic |
|
Ethanol |
4.14 | 17347304 17207112 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
11.84 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Dieldrin |
11.84 | 8742319 9539021 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylhexyl Phthalate |
11.84 | 11940454 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
11.84 | 16984957 |
MESH:D008113 |
Liver Neoplasms |
|
Urethane |
11.84 | 16391232 17559639 17093202 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
7.88 | 6135515 2876784 2876786 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Benzene |
7.88 | 12562636 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
7.88 | 12151625 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Benzene |
4.27 | 14698565 |
MESH:D008175 |
Lung Neoplasms |
|
Benzene |
4.31 | 12562636 |
MESH:D008175 |
Lung Neoplasms |
|
Sulindac |
4.31 | 19359593 15713900 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
4.31 | 11884234 19555203 |
MESH:D008175 |
Lung Neoplasms |
|
Urethane |
4.31 | 12957351 17195641 16926031 12117781 15166089 11062179 11807781 11497255 10822126 16337739 11893704 16788158 12466968 10530776 17255336 11246140 16204055 7750092 11323394 10779650 12765245 17093202 6695378 11552296 16289808 15136453 11544531 11074608 16391232 16007126 10997738 14587096 15902970 11307925 11992545 |
MESH:D008223 |
Lymphoma |
|
Benzene |
3.36 | 17584886 17119257 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Benzene |
3.92 | 12562636 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Benzene |
8.18 | 11921183 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
8.18 | 11807958 11408345 16891317 17203775 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tocopherols |
8.18 | 17927505 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
3.94 | 19453300 |
MESH:D008545 |
Melanoma |
|
Sulindac |
2.75 | 16642371 |
MESH:D008569 |
Memory Disorders |
|
Ethanol |
3.69 | 18411066 15451040 |
MESH:D001523 |
Mental Disorders |
|
Clozapine |
6.64 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
Haloperidol |
6.64 | 16856516 |
MESH:D008607 |
Mental Retardation |
|
Toluene |
3.45 | 9294310 |
MESH:D008654 |
Mesothelioma |
|
Tocopherols |
3.87 | 15878867 |
MESH:D024821 |
Metabolic Syndrome X |
|
Clozapine |
3.98 | 19142101 |
MESH:D019957 |
Motor Skills Disorders |
|
Toluene |
4.75 | 9294310 |
MESH:D009101 |
Multiple Myeloma |
|
Benzene |
3.29 | 17119195 |
MESH:D009137 |
Muscular Dystrophy, Animal |
|
Gentamicins |
5.74 | 18694830 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.60 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
2.87 | 16810080 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
3.34 | 7678174 18551238 |
MESH:D009369 |
Neoplasms |
|
Dieldrin |
4.95 | 8820588 |
MESH:D009369 |
Neoplasms |
|
Urethane |
4.95 | 15625555 |
MESH:D009374 |
Neoplasms, Experimental |
|
Urethane |
4.17 | 15582191 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.21 | 17289903 |
MESH:D009410 |
Nerve Degeneration |
|
Paraquat |
3.31 | 16893418 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
13.46 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
13.46 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
13.46 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
Benzene |
3.32 | 15643154 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Amphetamine |
12.05 | 15183010 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Oxidopamine |
12.05 | 18514411 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Sulindac |
12.05 | 17266991 16850258 |
MESH:D020078 |
Neurogenic Inflammation |
|
Xylenes |
5.51 | 19159661 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Chlorpyrifos |
3.80 | 15081274 |
MESH:D009765 |
Obesity |
|
Clozapine |
4.34 | 18515891 19142110 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
4.34 | 21332399 11836018 18674790 18457598 17217161 16723640 19632207 20518802 20132043 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
7.64 | 16049721 |
MESH:D009784 |
Occupational Diseases |
|
Benzene |
7.64 | 17479406 15727169 17119257 15612468 17178637 15935809 15576619 16737584 15913788 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
4.46 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
Benzene |
6.95 | 12562636 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
6.95 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Urethane |
6.95 | 16391232 |
MESH:D010146 |
Pain |
|
Sulindac |
6.44 | 3291741 |
MESH:D010146 |
Pain |
|
Xylenes |
6.44 | 3412491 19159661 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Ethanol |
5.05 | 12384795 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Sulindac |
5.05 | 11504793 16820089 |
MESH:D010300 |
Parkinson Disease |
|
Dieldrin |
5.03 | 11181820 17291500 16809432 16112328 11445065 |
MESH:D010300 |
Parkinson Disease |
|
Paraquat |
5.03 | 16510128 11445065 16140633 15451049 11124998 12911755 11181820 15824117 |
MESH:D010302 |
Parkinson Disease, Secondary |
|
Oxidopamine |
9.68 | 15893579 11771942 |
MESH:D010302 |
Parkinson Disease, Secondary |
|
Paraquat |
9.68 | 16190885 |
MESH:D010382 |
Peliosis Hepatis |
|
1-Naphthylisothiocyanate |
12.00 | 20133375 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
12.00 | 12520081 |
MESH:D010911 |
Pituitary Neoplasms |
|
Urethane |
4.90 | 16391232 |
MESH:D011014 |
Pneumonia |
|
Paraquat |
3.93 | 12504350 |
MESH:D011141 |
Polyuria |
|
Lithium Chloride |
5.47 | 19692487 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.06 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
7.76 | 10548101 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
7.76 | 11896295 11399792 11118676 11222880 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
8.98 | 20887781 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
8.98 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
2.97 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.97 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tocopherols |
2.97 | 12504091 |
MESH:D011507 |
Proteinuria |
|
Gentamicins |
4.24 | 15033597 |
MESH:D011595 |
Psychomotor Agitation |
|
Haloperidol |
4.44 | 11575062 |
MESH:D011618 |
Psychotic Disorders |
marker/mechanism |
|
| 14708030 |
MESH:D011618 |
Psychotic Disorders |
|
Clozapine |
7.86 | 15331141 |
MESH:D011618 |
Psychotic Disorders |
|
Haloperidol |
7.86 | 11575062 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.26 | 10548101 |
MESH:D011649 |
Pulmonary Alveolar Proteinosis |
|
27-hydroxycholesterol |
5.85 | 15466366 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Paraquat |
2.69 | 17997886 16324872 |
MESH:D012021 |
Reflex, Abnormal |
|
Pentobarbital |
5.49 | 10930210 |
MESH:D051437 |
Renal Insufficiency |
|
Gentamicins |
4.48 | 15728788 17132701 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Paraquat |
3.42 | 11700416 |
MESH:D012135 |
Respiratory Sounds |
|
Chlorpyrifos |
13.39 | 11874814 16611668 17119214 |
MESH:D012135 |
Respiratory Sounds |
|
Paraquat |
13.39 | 11874814 |
MESH:D012135 |
Respiratory Sounds |
|
Parathion |
13.39 | 17119214 11874814 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.33 | 18990726 |
MESH:D012140 |
Respiratory Tract Diseases |
|
Chlorpyrifos |
9.49 | 16611668 17119214 |
MESH:D012140 |
Respiratory Tract Diseases |
|
Parathion |
9.49 | 17119214 |
MESH:D012162 |
Retinal Degeneration |
|
Paraquat |
3.47 | 16458197 |
MESH:D012173 |
Retinitis |
|
Gentamicins |
5.74 | 18644591 |
MESH:D012559 |
Schizophrenia |
|
Clozapine |
3.76 | 18806925 20168265 11763009 17667964 11151749 19369910 18855531 20521320 20107430 16141801 17726453 17123785 20452607 20521326 20580759 |
MESH:D012559 |
Schizophrenia |
|
Haloperidol |
3.76 | 19369910 20107430 18513383 1830565 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
14.74 | 18551238 |
MESH:D012640 |
Seizures |
|
Dizocilpine Maleate |
14.74 | 17157343 12660363 11218047 |
MESH:D012640 |
Seizures |
|
Ethanol |
14.74 | 9754883 |
MESH:D012640 |
Seizures |
|
Pentobarbital |
14.74 | 10087439 9754883 |
MESH:D012640 |
Seizures |
|
Toluene |
14.74 | 9294310 6431079 |
MESH:D012729 |
Sex Chromosome Aberrations |
|
Chlorpyrifos |
5.55 | 6418539 |
MESH:D012878 |
Skin Neoplasms |
|
Okadaic Acid |
8.19 | 12628509 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
8.19 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Urethane |
8.19 | 11807781 |
MESH:D019082 |
Smith-Lemli-Opitz Syndrome |
|
27-hydroxycholesterol |
5.50 | 11254748 |
OMIM:270800 |
SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE |
|
27-hydroxycholesterol |
5.84 | 19812052 |
MESH:D019956 |
Stereotypic Movement Disorder |
|
Amphetamine |
5.88 | 1977408 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzene |
2.69 | 12562636 |
MESH:D013274 |
Stomach Neoplasms |
|
Ethanol |
2.69 | 18456281 |
MESH:D013276 |
Stomach Ulcer |
|
Ethanol |
3.08 | 16755016 11906479 9211565 17918041 17189318 9562338 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
3.46 | 16045194 16684133 |
MESH:D013375 |
Substance Withdrawal Syndrome |
|
Ethanol |
8.73 | 9754883 |
MESH:D013375 |
Substance Withdrawal Syndrome |
|
Pentobarbital |
8.73 | 11529278 9754883 |
MESH:D017180 |
Tachycardia, Ventricular |
|
Haloperidol |
4.21 | 20210726 |
MESH:D013733 |
Testicular Diseases |
|
Toluene |
9.51 | 10514026 10048760 |
MESH:D013733 |
Testicular Diseases |
|
Xylenes |
9.51 | 10514026 10048760 |
MESH:D013921 |
Thrombocytopenia |
|
1-Naphthylisothiocyanate |
4.29 | 20133375 |
MESH:D013953 |
Thymus Neoplasms |
|
Benzene |
4.43 | 10850423 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.36 | 12697716 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.15 | 19048282 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
2.07 | 16049721 |
MESH:D014570 |
Urologic Diseases |
|
cypermethrin |
5.33 | 16487989 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
3.79 | 10091137 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
4.47 | 14652134 |
MESH:D014594 |
Uterine Neoplasms |
|
Benzene |
8.39 | 12562636 |
MESH:D014594 |
Uterine Neoplasms |
|
Sulindac |
8.39 | 18645019 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.05 | 12125929 |
MESH:D019043 |
Vascular Neoplasms |
|
Urethane |
5.37 | 10620525 |
MESH:D015837 |
Vestibular Diseases |
|
Gentamicins |
5.02 | 18776599 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.71 | 15886252 |
MESH:D015430 |
Weight Gain |
|
Clozapine |
8.34 | 16402076 20107430 20521320 17502770 16141801 20564506 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
8.34 | 16723640 |
MESH:D015431 |
Weight Loss |
|
Clozapine |
4.55 | 17933447 |